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Abstract
Background: Human milk is fundamental for its nutritional properties and to protect newborns, but it is not sterile
and can sometime transmit bacteria. Few anecdotal cases suggest that breast milk could be a possible source of
group B Streptococcus (GBS) late onset disease, although the pathogenesis is not entirely understood.
Case presentation: We report 3 cases of GBS late onset disease in full-term newborns. Fresh breast milk cultures
yielded GBS, but mothers of neonates had no signs of mastitis and remained persistently GBS negative at
rectovaginal site.
Conclusions: Breast milk containing group B Streptococcus can be a risk factor for late onset disease. The persistent
negative maternal GBS status supports the assumption that newborns, colonised in the throat, could be the initial
source of GBS, while the mammary gland could act as a GBS replication site. It is unclear whether a low bacterial
load may represent only contamination rather than true milk infection.
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Background
Breast milk has primary importance for feeding of the
newborn, because of its nutritional properties and the
contribution to the development of host defences [1].
However, human milk is not sterile and can sometime
transmit bacteria. Group B Streptococcus (GBS) is a lead-
ing cause of neonatal infections in developed countries
[2]. Two distinct syndromes are recognized: early-onset
disease (EOD, from birth to day 6) and late-onset disease
(LOD, from day 7 to 89) [3]. Several case reports have
suggested breast milk as a possible source of GBS LOD
[4]. Nevertheless, the mechanisms of GBS transmission
and LOD pathogenesis are not yet clear. GBS gastro-
intestinal and genitourinary tract colonisation is com-
mon, and it ranges in pregnant women from 4 to 36%
[5, 6]. However, only 0.8 to 3.5% of mothers carry GBS
in their breast milk [7, 8].
We report 3 cases of LOD in full-term newborns who
were breastfed with GBS contaminated milk. The new-
borns’ mothers had no signs of mastitis and their recto-
vaginal swabs were permanently GBS negative (both at
prenatal screening and at the time of diagnosis of LOD).
These findings suggest that the transmission may occur
through a circular mechanism: the newborn (colonised
in the throat) could be the initial source of GBS, while
the mammary gland could act as a GBS replication site.
Case presentation
Case 1 (Table 1)
A Caucasian male neonate was born at 38 weeks’ gestations
by vaginal delivery. Rectovaginal screening culture was
negative for GBS. Birth weight was 3290 g; Apgar score was
9 and 10 at 1 and 5 min respectively. The newborn suffered
from a mild tachypnoea on day 1, but was healthy and
breastfed when discharged home on day 3. On day 9, he
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was admitted to the emergency department because of irrit-
ability and poor feeding. At admission, heart rate was
220 bpm. Blood testing showed mildly raised levels of lac-
tate (3.9 mmol/l), and procalcitonin (PCT, 3.24 μg/L).
Broad spectrum antibiotics (ampicillin and cefotaxime i.v.)
were promptly given after cultures collection. Urine test,
chest and abdominal ultrasounds found no source of infec-
tion. GBS was cultured in blood and in breast milk al-
though the mother had no signs of mastitis. Maternal
rectovaginal and urine cultures were sterile. Breastfeeding
was not discontinued but milk culture became sterile after
a 7 day course of oral amoxicillin was given to the mother.
The newborn promptly improved and after 7 days i.v. anti-
biotics were shifted to oral amoxicillin that was discontin-
ued on day 10. No recurrence of GBS was observed. Both
GBS strains isolated from neonatal blood and milk were
serotype III.
Case 2
A male neonate was born at 37 weeks’ gestation after vagi-
nal delivery to a Caucasian woman. Antenatal GBS screen-
ing was negative. Birth weight was 3375 g; Apgar score at
5 min was 10. The newborn was healthy and breastfed
when discharged home. On day 17, he was admitted to the
emergency department because of poor feeding, irritability
and fever (T > 38 °C). Broad spectrum i.v. antibiotics (ampi-
cillin and gentamicin) were given after cultures collection.
Laboratory tests showed severely raised CRP levels (22 mg/
dl) and CSF WBC (8000/mm3, with predominance of poly-
morphonuclear cells). Brain ultrasound study revealed a
mild enlargement of lateral ventricles. Blood, CSF and fresh
breast milk cultures yielded GBS. Maternal rectovaginal
and urine cultures were sterile and the woman had no signs
of mastitis. The infant was discharged home after a 14 days
course of i.v. ampicillin and had no further relapses of
LOD. Both neonatal and maternal GBS isolates were sero-
type III and had an identical genetic profile by Pulsed Field
Gel electrophoresis [9].
Case 3
A female was delivered vaginally (at 40 weeks’ gestation) to
a Caucasian woman whose GBS screening culture was
negative. The neonatal birth weight was 3176 g and Apgar
score at 5 min was 10. She was healthy and breastfed when
discharged home. On day 8 of life, the baby presented at
the emergency department with fever, poor feeding and
tachycardia. Laboratory tests showed raised CRP levels
(13,5 mg/dl). Broad spectrum antibiotics (ampicillin and
gentamicin) were given i.v. after collecting cultures (blood
and CSF). Lumbar puncture showed low glucose levels
Table 1 Demographics and clinical findings of the three cases of LOD and their own mothers
CASE 1 CASE 2 CASE 3
Gestational age, weeks 38 37 40
Sex M M F
Birth weight, g 3290 3375 3176
5 min Apgar score 10 10 10
Antenatal GBS screening Negative Negative Negative
GBS rectovaginal culture at diagnosis Negative Negative Negative
Breastfeeding Yes Yes Yes
Days at presentation of late-onset disease 9 17 8
Symptoms irritability, poor feeding irritability, poor feeding,
T° > 38 ° C
irritability, poor feeding,
T° > 38 °C
Blood culture GBS + GBS + GBS -
CSF culture Not done GBS + GBS +
Day of antibiotics 10 NA 12
Fresh breast milk culture GBS + GBS + GBS +
Mastitis No No No
Antibiotics given to the mother Yes No No
Breastfeeding during LOD Yes NA NA
Fresh milk culture after antibiotic therapy negative NA NA
GBS neonatal serotype III III NA
GBS maternal serotype III III NA
Lenght of stay, days 10 14 14
Recurrence no no no
GBS Group B streptococcus, F Female, LOD Late-onset disease, M Male, T° Temperature, NA Not available
Nicolini et al. BMC Pediatrics  (2018) 18:214 Page 2 of 4
(9 mg/dl), raised protein levels (300 mg/dl), and 6700 cells/
mm3 with predominance of polymorphonuclear cells
(95%). Blood culture was sterile whereas CSF and fresh
breast milk cultures yielded GBS (80.000 CFU/ml in breast
milk). The baby was given a 12 days course of ampicillin
and was discharged home 14 days after admission. No re-
currences were observed. The mother had no signs of mas-
titis and she was confirmed GBS-negative at rectovaginal
site at the time of diagnosis of LOD.
Discussion and conclusions
This report deals with three cases of LOD in full-term
neonates possibly attributed to the ingestion of breast
milk containing GBS. Cases presented with sepsis and/or
meningitis at day 9, 17 and 8, respectively. None of the
mothers had signs of mastitis and all were GBS-negative
at rectovaginal site (both at screening and at the time of
diagnosis of LOD). In case 1 and case 2, neonatal and
maternal GBS isolates were serotype III. Milk bacterial
count was available only in case 3.
Berardi et al. evaluated GBS colonisation in 160
mother-baby pairs. GBS was identified in 53 neonatal
throat cultures and 77 neonatal rectal cultures. GBS in
breast milk was associated with heavy neonatal colonisa-
tion [10]. However, the mechanism of transmission of
LOD through breastfeeding is poorly understood. The
retrograde theory hypothesizes that GBS, present in the
infant’s throat, colonises the mammary ducts during
breast-feeding. GBS load increases in the milk, and in turn
the infant is infected during breast-feeding (circular mech-
anism) [4]. Alternatively, some authors suggest that GBS
might reach the mammary gland through the transloca-
tion of bacteria from maternal gut via lymphatics [11].
A recent review of the literature analysed cases of LOD
in which the breast milk was tested positive for GBS [4].
The review pointed out that the role of breast milk in
LOD remains controversial, although the milk would be a
more convincing source when LOD occurs in a neonate
born to a GBS negative mother, delivered after planned
CS and when nosocomial sources are not identifiable. The
review also reported that less than half mothers with GBS
in breast milk had mastitis [4] and that most mothers
(59%) were GBS negative at antenatal screening. However,
Berardi et al. showed that only a few mothers (~ 25%) of
neonates with LOD were confirmed GBS negative at rec-
tovaginal site when they were retested at the time of diag-
nosis of LOD [12]. Therefore, the proportion of mothers
who actually carry GBS at rectovaginal site is certainly
underestimated if mothers GBS negative at screening are
not retested at the time of diagnosis of LOD.
In the current study, 3 cases of LOD occurred in 3 differ-
ent hospitals, therefore GBS strains are certainly unrelated.
All mothers were confirmed GBS-negative at rectovaginal
site. Newborns could have been colonised with GBS at
mucosal surface (throat) after birth (from caregivers or en-
vironmental sources) and subsequently they could have
transmitted GBS to mother’s mammary gland. Indeed,
in case 2, the GBS yielded from breast milk and neo-
nate showed an identical genetic profile. In these
cases a circular mechanism seems particularly sug-
gestive, whereas a bacterial translocation from mater-
nal gut is unlikely because of persistent negative GBS
rectovaginal culture.
Transition from silent breast duct colonisation to active
GBS multiplication depends on many factors, such as milk
stasis and bacterial load. Some investigators found that
mothers with mastitis had higher GBS bacterial load
(1.000.000 CFU/ml), than mothers without mastitis
(≤100.000 CFU/ml) [12]. The lower bacterial count could
suggest contamination during sampling rather than bacter-
ial active multiplication. In the current study, none of the
mothers had evidence of mastitis and milk bacterial count,
available only in 1 out of the 3 cultures, was 80.000 CFU/
ml. Some studies reported a total bacterial count <
106 CFU/ml as the physiological threshold of bacterial load
in human milk [13, 14]. The origin of milk bacteria is still
not well understood, but several studies confirmed the ex-
istence of a dynamic network between breast-milk and
newborn’s oral microbiota [15]. The causative role of breast
milk in LOD results from the interaction of several mater-
nal and neonatal factors. Prematurity, immature immune
system, bacterial load and lesions of the intestinal mucosal
barrier are recognised risk factors for progression to infec-
tion after ingestion of breast milk contaminated with GBS
[4, 16]. This study is subjected to some limitations. Al-
though mothers were apparently negative, we can not
firmly rule out that they had a light colonisation, un-
detected by rectovaginal cultures. However, this eventuality
seems unlikely. Furthermore, we have no data regarding
the genetic profiles of most GBS isolated from mothers.. Fi-
nally, surface cultures were not collected from family mem-
bers and neonates. This additional information could
contribute to understand modes and mechanisms of GBS
transmission.
Identifying the underlying mechanisms of postnatal
transmission of GBS will be crucial to prevent cases of
LOD. To date studies have not recognized the predom-
inant mode (maternal, nosocomial or community) of
postnatal GBS transmission. GBS in breast milk can be a
risk factor for GBS LOD. The persistent culture-negative
maternal GBS status suggests the transmission through
a circular mechanism, with the newborn (colonised at
the throat) as the initial source of GBS, and the
mammary gland as a GBS replication site. High or
low bacterial load in breast milk might help distin-
guish cases in which breast milk is actually infected
from cases where breast milk is only “contaminated”
during sampling.
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Testing maternal GBS rectovaginal status and col-
lecting breast milk culture at the time of LOD diag-
nosis could help to shed light on the mechanisms of
GBS LOD.
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